Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 721 to 740 of 17605

Pub YearTitleAuthor(s)
2022A partially hydrolyzed whey formula provides adequate nutrition in high-risk infants for allergy이수영, 정경욱
2018A party to celebrate having an article published정민석
2019A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients안재홍
2011A Path Model Predicting Medication Adherence and Self-care of Low-income Older Adults with Hypertension이은현
2015A patient with atonic seizures mimicking transient ischemic attacks.안영실, 최준영
2008A Patient with Frontotemporal Dementia Presenting with Limb-Kinetic Apraxia문소영
2016A Patient with Henoch-Schönlein Purpura with Intussusception and intractable Nephritis배기수, 임현이, 홍정
2009A Patient’s Right to Know and Self-Determination김용순, 방경숙, 유문숙
2008A Patterns of Care Study of the Various Radiation Therapies for Prostate Cancer among Korean Radiation Oncologists in 2006오영택
2020A peptide derived from the core beta-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models서창희
2004A phagemid system enabling easy estimation of the combinatorial antibody library size.권명희, 김경민, 박선, 신호준
2016A Phantom Study for Attenuation Change and Detection of Calcification in Lung Nodules According to Variation of Examination Techniques in Low Dose CT조재용
2018A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of FcgammaRIIB박상면
2018A pharmaceutical composition for preventing or treating neurodegenerative diseases comprising inhibitor for expressing or activating of SHP-1/-2박상면
2007A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases남동호
2010A pharmaceutical composition for the treatment or prevention of allergic disease and autoimmune disease, use thereof, and a method for treatment or prevention of allergic disease and autoimmune disease남동호
2020A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis서창희
2015A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease.손영배
2014A phase 2 trial of radiation therapy with concurrent paclitaxel chemotherapy after surgery in patients with high-risk endometrial cancer: a Korean Gynecologic Oncologic Group study.유희석
2016A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan박해심

Browse